These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 12786634

  • 1. Short- and long-term therapy for reflux oesophagitis in the elderly: a multi-centre, placebo-controlled study with pantoprazole.
    Pilotto A, Leandro G, Franceschi M, Ageing and Acid-Related Disease Study Group.
    Aliment Pharmacol Ther; 2003 Jun 01; 17(11):1399-406. PubMed ID: 12786634
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the efficacy of pantoprazole vs. nizatidine in the treatment of erosive oesophagitis: a randomized, active-controlled, double-blind study.
    Kovacs TO, Wilcox CM, DeVault K, Miska D, Bochenek W, Pantoprozole US Gerd Study Group B.
    Aliment Pharmacol Ther; 2002 Dec 01; 16(12):2043-52. PubMed ID: 12452936
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. One-year prophylactic efficacy and safety of pantoprazole in controlling gastro-oesophageal reflux symptoms in patients with healed reflux oesophagitis.
    Mössner J, Koop H, Porst H, Wübbolding H, Schneider A, Maier C.
    Aliment Pharmacol Ther; 1997 Dec 01; 11(6):1087-92. PubMed ID: 9663834
    [Abstract] [Full Text] [Related]

  • 8. Pantoprazole provides rapid and sustained symptomatic relief in patients treated for erosive oesophagitis.
    Bochenek WJ, Mack ME, Fraga PD, Metz DC.
    Aliment Pharmacol Ther; 2004 Nov 15; 20(10):1105-14. PubMed ID: 15569113
    [Abstract] [Full Text] [Related]

  • 9. Prevention of erosive oesophagitis relapse with pantoprazole.
    Richter JE, Fraga P, Mack M, Sabesin SM, Bochenek W, Pantoprazole US GERD Study Group.
    Aliment Pharmacol Ther; 2004 Sep 01; 20(5):567-75. PubMed ID: 15339328
    [Abstract] [Full Text] [Related]

  • 10. Safety and efficacy of pantoprazole 40 mg daily as relapse prophylaxis in patients with healed reflux oesophagitis-a 2-year follow-up.
    Van Rensburg CJ, Honiball PJ, Van Zyl JH, Grundling HD, Eloff FP, Spies SK, Simjee AE, Theron I, Fischer R, Louw JA.
    Aliment Pharmacol Ther; 1999 Aug 01; 13(8):1023-8. PubMed ID: 10468676
    [Abstract] [Full Text] [Related]

  • 11. Pantoprazole versus lansoprazole in French patients with reflux esophagitis.
    Dupas JL, Houcke P, Samoyeau R, French Collaborative Pantaprazole Study Group.
    Gastroenterol Clin Biol; 2001 Mar 01; 25(3):245-50. PubMed ID: 11395670
    [Abstract] [Full Text] [Related]

  • 12. Long-term clinical outcome of elderly patients with reflux esophagitis: a six-month to three-year follow-up study.
    Pilotto A, Franceschi M, Leandro G, Novello R, Di Mario F, Valerio G.
    Am J Ther; 2002 Mar 01; 9(4):295-300. PubMed ID: 12115018
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease.
    Armstrong D, Paré P, Pericak D, Pyzyk M, Canadian Pantoprazole GERD Study Group.
    Am J Gastroenterol; 2001 Oct 01; 96(10):2849-57. PubMed ID: 11695354
    [Abstract] [Full Text] [Related]

  • 15. A double-blind study of pantoprazole and omeprazole in the treatment of reflux oesophagitis: a multicentre trial.
    Mössner J, Hölscher AH, Herz R, Schneider A.
    Aliment Pharmacol Ther; 1995 Jun 01; 9(3):321-6. PubMed ID: 7654895
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and tolerability of 20 mg pantoprazole versus 300 mg ranitidine in patients with mild reflux-oesophagitis: a randomized, double-blind, parallel, and multicentre study.
    van Zyl JH, de K Grundling H, van Rensburg CJ, Retief FJ, O'Keefe SJ, Theron I, Fischer R, Bethke T.
    Eur J Gastroenterol Hepatol; 2000 Feb 01; 12(2):197-202. PubMed ID: 10741935
    [Abstract] [Full Text] [Related]

  • 17. Comparable efficacy of pantoprazole and omeprazole in patients with moderate to severe reflux esophagitis. Results of a multinational study.
    Körner T, Schütze K, van Leendert RJ, Fumagalli I, Costa Neves B, Bohuschke M, Gatz G.
    Digestion; 2003 Feb 01; 67(1-2):6-13. PubMed ID: 12743434
    [Abstract] [Full Text] [Related]

  • 18. Comparable clinical efficacy and tolerability of 20 mg pantoprazole and 20 mg omeprazole in patients with grade I reflux oesophagitis.
    Bardhan KD, Van Rensburg C.
    Aliment Pharmacol Ther; 2001 Oct 01; 15(10):1585-91. PubMed ID: 11563998
    [Abstract] [Full Text] [Related]

  • 19. Pantoprazole maintenance therapy prevents relapse of erosive oesophagitis.
    Metz DC, Bochenek WJ, Pantoprazole US GERD Study Group.
    Aliment Pharmacol Ther; 2003 Jan 01; 17(1):155-64. PubMed ID: 12492745
    [Abstract] [Full Text] [Related]

  • 20. A comparison of omeprazole, lansoprazole and pantoprazole in the maintenance treatment of severe reflux oesophagitis.
    Jaspersen D, Diehl KL, Schoeppner H, Geyer P, Martens E.
    Aliment Pharmacol Ther; 1998 Jan 01; 12(1):49-52. PubMed ID: 9692700
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.